1. Gravallese EM, Firestein GS (2023): Rheumatoid arthritis – common origins, divergent mechanisms. N Engl J Med 388: 529-542.
2.
Myers LK, Ouyang YX, Patel JR, et al. (2022): Role of citrullinated collagen in autoimmune arthritis. Int J Mol Sci 23: 9833.
3.
Trier NH, Houen G (2023): Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis. Expert Rev Mol Diagn 23: 895-911.
4.
Muller S, Radic M (2015): Citrullinated autoantigens: From diagnostic markers to pathogenetic mechanisms. Clin Rev Allergy Immunol 2015; 49: 232-239.
5.
Konig MF, Abusleme L, Reinholdt J, et al. (2016): Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med 8: 369ra176.
6.
Šenolt L, Grassi W, Szodoray P (2014): Laboratory biomarkers or imaging in the diagnostics of rheumatoid arthritis? BMC Med 12: 49.
7.
Sokolova MV, Schett G, Steffen U (2022): Autoantibodies in rheumatoid arthritis: Historical background and novel findings. Clin Rev Allergy Immunol 63: 138-151.
8.
Chakraborty S, Kubatzky KF, Mitra DK (2019): An update on interleukin-9: From its cellular source and signal transduction to its role in immunopathogenesis. Int J Mol Sci 20: 2113.
9.
Ciccia F, Guggino G, Rizzo A, et al. (2015): Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis. Rheumatology 54: 2264-2272.
10.
Dantas AT, Marques CDL, da Rocha Junior LF, et al. (2015): Increased serum interleukin-9 levels in rheumatoid arthritis and systemic lupus erythematosus: Pathogenic role or just an epiphenomenon? Dis Markers 2015: 519638.
11.
Chowdhury K, Kumar U, Das S, et al. (2018): Synovial IL-9 facilitates neutrophil survival, function and differentiation of Th17 cells in rheumatoid arthritis. Arthritis Res Ther 20: 18.
12.
Leipe J, Grunke M, Dechant C, et al. (2010): Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 62: 2876-2885.
13.
Zhu Y, Zhang L, Zhang X, et al. (2022): Tripterygium wilfordii glycosides ameliorates collagen-induced arthritis and aberrant lipid metabolism in rats. Front Pharmacol 13: 938849.
14.
Palma ZTG, Taipeiro EF, Spadella MA, et al. (2016): Collagen-induced arthritis increases inducible nitric oxide synthase not only in aorta but also in the cardiac and renal microcirculation of mice. Clin Exp Immunol 183: 341-349.
15.
Dong C (2021): Cytokine regulation and function in T cells. Annu Rev Immunol 39: 51-76.
16.
Elyaman W, Bradshaw EM, Uyttenhove C, et al. (2009): IL-9 induces differentiation of TH17 cells and enhances function of FoxP3h natural regulatory T cells. Proc Natl Acad Sci 106: 12885-12890.
17.
Cutolo M, Campitiello R, Gotelli E, Soldano S (2022): The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis. Front Immunol 13: 867260.
18.
Sparks JA (2019): Rheumatoid arthritis. Ann Intern Med 170: ITC-ITC16.
19.
Triguero-Martínez A, de la Fuente H, Montes N, et al. (2020): Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis. Sci Rep 10: 17799.
20.
Hughes-Austin JM, Deane KD, Derber LA, et al. (2013): Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 72: 901-907.
21.
Ferris J, Cooper S, Roessner K, Hochberg M (1990): Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. J Rheumatol 17: 880-884.
22.
Hu F, Jiang X, Guo C, et al. (2020): Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study. Nat Commun 11: 1911.
23.
Després N, Boire G, Lopez-Longo FJ, Ménard HA (1994): The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 21: 1027-1033.
24.
Deng Y, Wang Z, Chang C, et al. (2017): Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials. Hum Immunol 78: 120-128.
25.
Elyaman W, Bradshaw EM, Uyttenhove C, et al. (2009): IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A 106: 12885-12890.
26.
Nowak EC, Weaver CT, Turner H, et al. (2009): IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 206: 1653-1660.
27.
Chen Z, Bozec A, Ramming A, Schett G (2018): Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol 15: 9-17.
28.
Heim J, Almanzar G, Schmalzing M, Gernert M, Tony H-P, Prelog M. Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine Conditions. Frontiers in Immunology. 2021;12.
29.
Rauber S, Luber M, Weber S, et al. (2017): Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat Med 23: 938-944.
30.
Fukui S, Iwamoto N, Takatani A, et al. (2017): M1 and M2 monocytes in rheumatoid arthritis: A contribution of imbalance of M1/M2 monocytes to osteoclastogenesis. Front Immunol 8: 1958.
